| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.06 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |